Related Experiment Video

Updated: Jul 4, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.1K

On emerging enzyme replacement therapies for neuronopathic mucopolysaccharidosis II

Y Sato1, P Yoshida1, T Yamamoto1

  • 1JCR Pharmaceuticals, Hyogo, Japan.

Molecular Genetics and Metabolism
|January 26, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.4K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

6.3K

Related Experiment Videos

Last Updated: Jul 4, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.1K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.4K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

6.3K

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K

Articles linked to this work by shared authors, journal, and citation graph.

Production, physiological response, and calcium and magnesium balance of lactating Holstein cows fed different sources of supplemental magnesium with or without ruminal buffer.

Journal of dairy science·2022

Postpartum atypical hemolytic uremic syndrome: Evaluating thrombotic microangiopathy in the pregnant woman.

Obstetric medicine·2021

Role of Divalent Metal Ions on Activity and Stability of Thermostable Dipeptidase from Bacillus stearothermophilus.

Bioscience, biotechnology, and biochemistry·2016

A toll-like receptor 3 single nucleotide polymorphism in Japanese patients with sarcoidosis.

Tissue antigens·2015

Enhanced performance of dye-sensitized solar cells based on TiO2 nanotube membranes using an optimized annealing profile.

Chemical communications (Cambridge, England)·2014

Demonstration of a 3-dB directional coupler with enhanced robustness to gap variations for silicon wire waveguides.

Optics express·2014

Metabolic alterations associated with immune dysfunction in lysinuric protein intolerance.

Molecular genetics and metabolism·2026

Population-based newborn screening for inherited metabolic diseases in Beijing, China: findings from 404,990 infants.

Molecular genetics and metabolism·2026

Longitudinal biochemical profiles in beta-ketothiolase deficiency: Phase-dependent diagnostic challenges and metabolic variability.

Molecular genetics and metabolism·2026

Diagnostic utility of FGF-21 and GDF-15 for differentiating primary mitochondrial diseases from lysosomal storage disorders associated with secondary mitochondrial dysfunction: a machine learning-based multimetabolite approach.

Molecular genetics and metabolism·2026

Bone mineral density in participants with phenylalanine hydroxylase (PAH) deficiency: a report from the PHEFREE rare disorders consortium.

Molecular genetics and metabolism·2026

Human cell-based models for urea cycle research: From gene regulation and ureagenesis to disease modeling and therapeutic development.

Molecular genetics and metabolism·2026

Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.

Journal of the American College of Cardiology·2026

Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

JAMA·2026

Advanced therapy medicinal products in Saudi Arabia: Regulation and development.

Regenerative therapy·2026

289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands.

Neuromuscular disorders : NMD·2026

ADHERENCE PATTERNS AND THEIR DETERMINANTS TO CFTR MODULATORS IN FRANCE.

Respiratory medicine·2026

Photobiomodulation therapy in the management of chronic wounds: From molecular mechanisms to translational clinical evidence.

Biochimie·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us